Emory University Crinetics Pharmaceuticals, Inc. Transaction History

Emory University

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$21.48 - $27.71 $2.08 Million - $2.69 Million	-97,035 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$21.07 - $29.31 $233,687 - $325,077	11,091 Added 12.9%	97,035 $2.21 Million
Q4 2018 Feb 12, 2019	BUY	$22.4 - $35.39 $1.93 Million - $3.04 Million	85,944 New	85,944 $2.58 Million

242

79.6M

23.3K

44.3K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.98B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Emory University, based on Form 13F filings with the SEC.

Stay updated on Emory University with notifications on news.